Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-13

Clinical Trial Update: Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cognitive behavioral therapy with or without armodafinil for insomnia and fatigue after chemotherapy in breast cancer patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NUVIGIL (armodafinil)

Snippet

Sponsor: University of Rochester | Conditions: Insomnia, Fatigue | Phase 2 | Status: COMPLETED | Results posted: 2015-03-13